Advanced Recovery Orthopaedic Program (AROP) Anaesthetic Guideline
|
SESLHDGL/059 |
|
Aerosol-generating interventions (AGI) for conditions during the COVID-19 pandemic period
|
SESLHDPR/754 |
|
Corporate Records Management Framework
|
SESLHDHB/022 |
|
Entecavir for HBV reactivation in Renal Patients
|
SESLHDPR/726 |
|
Enterprise Risk Management
|
SESLHDPR/304 |
|
Health and Safety Representatives
|
SESLHDPR/730 |
|
Health, Safety and Wellbeing Risk Management
|
SESLHDPR/212 |
|
Injury Management and Return to Work
|
SESLHDPR/276 |
|
Injury Management – Redeployment of Injured Employees under Workers Compensation Procedure
|
SESLHDPR/279 |
|
Management of Acute Viral Respiratory Illness (including influenza and COVID-19)
|
SESLHDPR/581 |
|
Management of Organisational Restructures and Other Reforms in SESLHD
|
SESLHDPR/744 |
|
Noise Risk Management
|
SESLHDPR/394 |
|
Nursing and Midwifery Registration
|
SESLHDPD/030 |
|
Product – Clinical Product Notices, Recalls and Safety Alerts
|
SESLHDPR/319 |
|
Radiation Safety - Calibration and Quality Assurance Procedures for Radiological and Radiation Safety Instruments
|
SESLHDPR/553 |
|
Radiation Safety - Death Procedures for Bodies Containing Radioactive Material
|
SESLHDPR/533 |
|
Radiation Safety - Ionising Radiation Procedure
|
SESLHDPD/296 |
|
Radiation Safety - Management of Radiation Apparatus
|
SESLHDPR/550 |
|
Radiation safety - personal monitoring
|
SESLHDPR/543 |
|
Radiation Safety - Quality Assurance in Radiotherapy
|
SESLHDPR/532 |
|
Radiation Safety - Radiation Exposure and Risk
|
SESLHDPR/554 |
|
Radiation safety - record keeping
|
SESLHDPR/540 |
|
Radiation safety - response to external emergencies involving radioactivity or exposure to ionising radiation
|
SESLHDPR/545 |
|
Radiation Safety - Security of Radioactive Sources
|
SESLHDPD/149 |
|
Radiation Safety - Shielding and Facility Design
|
SESLHDPR/536 |
|
Radiation Safety - Transport of Radioactive Substances
|
SESLHDPR/534 |
|
Radiation Safety - X-Ray Protective Clothing
|
SESLHDPR/732 |
|
Radiation Safety Training
|
SESLHDPR/537 |
|
Radiation Safety – Handling, Investigation and Reporting of Radiation Incidents
|
SESLHDPR/558 |
|
Radiation Safety – Minimising Radiation Exposure in Laboratories
|
SESLHDPR/541 |
|
Radiation Safety – Optimisation of Radiation Exposures in Nuclear Medicine
|
SESLHDPR/552 |
|
Radiation Safety – Optimise Exposures in Diagnostic and Interventional Radiology
|
SESLHDPR/551 |
|
Radiation Safety – Optimise Exposures in Radiotherapy
|
SESLHDPR/535 |
|
Radiation Safety – Protection of Staff and the General Public in Departments performing Diagnostic or Interventional Radiology
|
SESLHDPR/538 |
|
Radiation Safety – Protection of Staff and the general public in Nuclear Medicine
|
SESLHDPR/557 |
|
Radiation Safety – Protection of staff and the public during radiation oncology procedures
|
SESLHDPR/555 |
|
Radiation Safety – Protection of Staff in operating theatres
|
SESLHDPR/556 |
|
Radiation Safety – Radiation Exposure of Volunteers for Research Purposes
|
SESLHDPR/559 |
|
Radiation Safety – Radiation Safety in Ward Areas
|
SESLHDPR/539 |
|
Radiation Safety – Regulatory Requirements
|
SESLHDPR/542 |
|
Radiation Safety – Storage and Disposal of Radioactive Waste
|
SESLHDPR/544 |
|
Ravulizumab
|
SESLHDPR/684 |
|
Recognising and responding to abuse and violence of older people
|
SESLHDPR/598 |
|
Records - destruction of
|
SESLHDPR/220 |
|
Records - Management of Paper Originals of Imaged Records
|
SESLHDPR/222 |
|
Records Management
|
SESLHDPD/196 |
|
Records Management - Management of emails
|
SESLHDPR/221 |
|
Records Management – Disaster Management
|
SESLHDPR/219 |
|
Records Management – Retention Periods
|
SESLHDPD/203 |
|
Records Management – Storage and Protection
|
SESLHDPR/218 |
|
Recruitment and appointment of senior medical and dental officers
|
SESLHDPR/625 |
|
Reducing Cardiothoracic Surgical Site Infections through use of a Cardiothoracic Surgical Site Infection Care Bundle Guideline
|
SESLHDGL/066 |
|
Referral to Palliative Care
|
SESLHDGL/100 |
|
Referral to the Coroner in Maternity Services
|
SESLHDBR/007 |
|
Release of Patient Health Information Related to an Insurance / Compensation Claim
|
SESLHDPR/675 |
|
Reporting of notifiable Adverse Events Following Immunisation (AEFI) – local reporting process for COVID-19 Vaccination
|
SESLHDBR/096 |
|
Reporting Policy (Internal and External Channels)
|
SESLHDPD/266 |
|
Research Ethics and Governance Complaints
|
SESLHDPR/733 |
|
Resolving Unsatisfactory Performance
|
SESLHDPR/379 |
|
Respiratory Equipment – Cleaning and Decontamination
|
SESLHDPR/738 |
|
Responsible Conduct in Research
|
SESLHDPD/268 |
|
Restrictive practices with adult patients
|
SESLHDPR/483 |
|
Rituximab
|
|
|
Rivaroxaban
|
SESLHDPR/601 |
|
Rooming in for Healthy Babies
|
SESLHDPD/158 |
|
Rostering Best Practice
|
SESLHDPR/529 |
|
Ryzodeg® - Insulin degludec/insulin aspart (Ryzodeg® 70/30) Prescribing Protocol
|
SESLHDPR/650 |
|
Safety Incident Report Management
|
SESLHDPR/727 |
|
SESLHD Research Fees
|
SESLHDPD/332 |
|
Sterilisation - Records Management
|
SESLHDPR/514 |
|
Storage and Retention of standardised testing protocols
|
SESLHDPR/686 |
|
Systemic review of clinical practice or lookback process for clinicians of concern
|
SESLHDPR/746 |
|
Women who choose to refuse recommended monitoring and treatment in Maternity Services in SESLHD
|
SESLHDPR/482 |
|